VYLOY™ POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL
Product details
Registration number: SIN17197P
Classification: Prescription Only
Active ingredients: Zolbetuximab
Strength: 100mg/vial
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS
Registrant: ASTELLAS PHARMA SINGAPORE PTE. LTD.
ATC code: L01FX31
HSA approval date: 6 March 2025
Manufacturer(s):
- Simtra Deutschland GmbH
- Astellas Pharma Inc. (Yaizu Technology Center)
Manufacturing country/countries: GERMANY; JAPAN
What are the HSA registration number and classification for VYLOY™ POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN17197P
Classification: Prescription Only
What active ingredients and strength are recorded for VYLOY™ POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Zolbetuximab
Strength: 100mg/vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for VYLOY™ POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS
Who is the recorded registrant for VYLOY™ POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Registrant: ASTELLAS PHARMA SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for VYLOY™ POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Simtra Deutschland GmbH
- Astellas Pharma Inc. (Yaizu Technology Center)
Manufacturing country/countries: GERMANY; JAPAN
Where can I look up VYLOY™ POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN17197P or the exact product name VYLOY™ POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL. The general register link does not preselect this product.
What are the source dates for this VYLOY™ POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this VYLOY™ POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 100MG/VIAL record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN17197P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)